Investigators evaluated bioequivalence of pramipexole dihydrochloride extended-release tablets in Chinese healthy volunteers under fasting versus fed conditions. The pharmacokinetic comparison aims to clarify absorption and exposure changes tied to food intake, supporting dosing guidance for a therapy used for movement-disorder indications where exposure consistency is clinically important.